Literature DB >> 29985752

Methods for the analysis of multiple endpoints in small populations: A review.

Robin Ristl1, Susanne Urach1, Gerd Rosenkranz1, Martin Posch1.   

Abstract

While current guidelines generally recommend single endpoints for primary analyses of confirmatory clinical trials, it is recognized that certain settings require inference on multiple endpoints for comprehensive conclusions on treatment effects. Furthermore, combining treatment effect estimates from several outcome measures can increase the statistical power of tests. Such an efficient use of resources is of special relevance for trials in small populations. This paper reviews approaches based on a combination of test statistics or measurements across endpoints as well as multiple testing procedures that allow for confirmatory conclusions on individual endpoints. We especially focus on feasibility in trials with small sample sizes and do not solely rely on asymptotic considerations. A systematic literature search in the Scopus database, supplemented by a manual search, was performed to identify research papers on analysis methods for multiple endpoints with relevance to small populations. The identified methods were grouped into approaches that combine endpoints into a single measure to increase the power of statistical tests and methods to investigate differential treatment effects in several individual endpoints by multiple testing.

Keywords:  Combined outcomes; composite endpoints; multiple endpoints; multiple testing; multivariate responses; rare diseases; small populations

Mesh:

Year:  2018        PMID: 29985752     DOI: 10.1080/10543406.2018.1489402

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  9 in total

1.  Assessment of Treatment Effect With Multiple Outcomes in 2 Clinical Trials of Patients With Duchenne Muscular Dystrophy.

Authors:  Daniel Li; Craig M McDonald; Gary L Elfring; Marcio Souza; Joseph McIntosh; Dae Hyun Kim; Lee-Jen Wei
Journal:  JAMA Netw Open       Date:  2020-02-05

Review 2.  Review of neuropsychological outcomes in isolated methylmalonic acidemia: recommendations for assessing impact of treatments.

Authors:  Susan E Waisbren
Journal:  Metab Brain Dis       Date:  2022-03-29       Impact factor: 3.655

3.  Read-through approach for stop mutations in Duchenne muscular dystrophy. An update.

Authors:  Luisa Politano
Journal:  Acta Myol       Date:  2021-03-31

4.  Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial.

Authors:  Christoph Herrmann-Lingen; Christian Albus; Martina de Zwaan; Franziska Geiser; Katrin Heinemann; Martin Hellmich; Matthias Michal; Monika Sadlonova; Ralf Tostmann; Rolf Wachter; Birgit Herbeck Belnap
Journal:  BMC Cardiovasc Disord       Date:  2020-12-10       Impact factor: 2.298

5.  Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model.

Authors:  Alireza Safa; Allison R Lau; Sydney Aten; Karl Schilling; Karen L Bales; Victoria A Miller; Julie Fitzgerald; Min Chen; Kasey Hill; Kyle Dzwigalski; Karl Obrietan; Mitch A Phelps; Wolfgang Sadee; John Oberdick
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

6.  A 16-week randomized controlled trial of a fish oil and whey protein-derived supplement to improve physical performance in older adults losing autonomy-A pilot study.

Authors:  Anne-Julie Tessier; Julia Lévy-Ndejuru; Audrey Moyen; Marissa Lawson; Marie Lamarche; Joseé A Morais; Amritpal Bhullar; Francis Andriamampionona; Vera C Mazurak; Stéphanie Chevalier
Journal:  PLoS One       Date:  2021-08-23       Impact factor: 3.240

7.  Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol.

Authors:  Nicolas Waespe; Sven Strebel; Tiago Nava; Chakradhara Rao S Uppugunduri; Denis Marino; Veneranda Mattiello; Maria Otth; Fabienne Gumy-Pause; André O Von Bueren; Frederic Baleydier; Luzius Mader; Adrian Spoerri; Claudia E Kuehni; Marc Ansari
Journal:  BMJ Open       Date:  2022-01-24       Impact factor: 2.692

8.  A Joint Model Considering Measurement Errors for Optimally Identifying Tumor Mutation Burden Threshold.

Authors:  Yixuan Wang; Xin Lai; Jiayin Wang; Ying Xu; Xuanping Zhang; Xiaoyan Zhu; Yuqian Liu; Yang Shao; Li Zhang; Wenfeng Fang
Journal:  Front Genet       Date:  2022-08-04       Impact factor: 4.772

9.  TMBcat: A multi-endpoint p-value criterion on different discrepancy metrics for superiorly inferring tumor mutation burden thresholds.

Authors:  Yixuan Wang; Xin Lai; Jiayin Wang; Ying Xu; Xuanping Zhang; Xiaoyan Zhu; Yuqian Liu; Yang Shao; Li Zhang; Wenfeng Fang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.